Tokyo, Jan. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060367) titled 'An Observational Study on Effectiveness and Safety of Alluminox therapy for recurrent Nasopharyngeal carcinoma' on Jan. 15.
Study Type:
Observational
Primary Sponsor:
Institute - National Cancer Center Hospital East
Condition:
Condition - Nasopharyngeal carcinoma
Classification by malignancy - Malignancy
Genomic information - YES
Objective:
Narrative objectives1 - This study aims to evaluate the efficacy and safety of head and neck Aluminox therapy in patients with locally recurrent nasopharyngeal carcinoma after radiotherapy conducted as part of standard insurance-covered medical care. In addition, exploratory a...